Stockholders' Equity

6 Months Ended

Jun. 30, 2022

Stockholders' Equity Note [Abstract]

Stockholders' Equity

9. Stockholders’ Equity

Stock Option Plans

During the six months ended June 30, 2022 and 2021, the Company granted stock options to employees to purchase an aggregate of 1,171,175 and 1,375,310 shares respectively, of the Company’s common stock. The weighted-average grant-date fair value of the employee stock options granted during the six months ended June 30, 2022 and 2021 were $7.37 and $4.98 per share, respectively.

Restricted Stock Units

During the six months ended June 30, 2022, the Company granted 359,534 restricted stock units (“RSUs”) The weighted average grant-date fair value of RSUs granted during the six months ended June 30, 2022 was $18.28. The Company did not grant RSUs during the six months ended June 30, 2021.

Share-Based Compensation Expense

Share-based compensation expense is reflected in operating expenses in the condensed statements of operations and comprehensive loss as follows (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2021		2022		2021
Sales and marketing	$	690	$	370	$	1,221	$	517
Research and development		176		103		326		166
General and administrative		1,097		402		1,825		594
Total	$	1,963	$	875	$	3,372	$	1,277